While this increase in endogenous GCs appears to have predominately anti-inflammatory effects, as demonstrated by global 11β-HSD1 and GR inhibition, endogenous GCs may also play a role in the progression of RA, depending on the cell type involved. Here, NR3C1 is linked to rheumatoid arthritis.